"Fallopian Tube Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.
| Descriptor ID |
D005185
|
| MeSH Number(s) |
C04.588.945.418.365 C13.351.500.056.390.390 C13.351.937.418.365
|
| Concept/Terms |
Fallopian Tube Neoplasms- Fallopian Tube Neoplasms
- Fallopian Tube Neoplasm
- Neoplasm, Fallopian Tube
- Neoplasms, Fallopian Tube
Fallopian Tube Cancer- Fallopian Tube Cancer
- Cancer, Fallopian Tube
- Cancers, Fallopian Tube
- Fallopian Tube Cancers
- Cancer of the Fallopian Tube
|
Below are MeSH descriptors whose meaning is more general than "Fallopian Tube Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Fallopian Tube Neoplasms".
This graph shows the total number of publications written about "Fallopian Tube Neoplasms" by people in this website by year, and whether "Fallopian Tube Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 3 | 2 | 5 |
| 2010 | 5 | 0 | 5 |
| 2011 | 6 | 1 | 7 |
| 2012 | 2 | 1 | 3 |
| 2013 | 2 | 1 | 3 |
| 2014 | 7 | 1 | 8 |
| 2015 | 2 | 2 | 4 |
| 2016 | 6 | 0 | 6 |
| 2017 | 4 | 1 | 5 |
| 2018 | 0 | 1 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 5 | 0 | 5 |
| 2021 | 2 | 0 | 2 |
| 2022 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fallopian Tube Neoplasms" by people in Profiles.
-
Isolated Metastasis to Fallopian Tube Mucosa by Low-Grade Appendiceal Mucinous Neoplasm: Report of Two Cases. Int J Surg Pathol. 2023 Aug; 31(5):646-650.
-
Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer. J Clin Oncol. 2022 08 10; 40(23):2568-2577.
-
Precursors in the ovarian stroma: another pathway to explain the origin of ovarian serous neoplasms. Hum Pathol. 2022 09; 127:136-145.
-
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis. J Clin Oncol. 2022 06 10; 40(17):1879-1891.
-
TP53 variant allele frequency correlates with the chemotherapy response score in ovarian/fallopian tube/peritoneal high-grade serous carcinoma. Hum Pathol. 2021 09; 115:76-83.
-
Ovarian Mixed Epithelial Carcinoma With Extensive Bilateral Fallopian Tubes Metastases by the Low-grade Serous Carcinoma Component Mimicking Serous Tubal Intraepithelial Carcinoma: Case Presentation and Literature Review. Int J Gynecol Pathol. 2021 May 01; 40(3):305-309.
-
Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer. Int J Gynecol Cancer. 2020 11; 30(11):1768-1774.
-
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum. J Clin Oncol. 2020 11 10; 38(32):3753-3762.
-
Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease. Int J Gynecol Pathol. 2020 Jul; 39(4):305-312.
-
Demcizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal, and fallopian tube cancer: The SIERRA open-label phase Ib trial. Gynecol Oncol. 2020 05; 157(2):386-391.